Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $560
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch maintains a Buy rating on Intuitive Surgical and raises the price target from $512 to $560.
August 22, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch has reiterated a Buy rating for Intuitive Surgical and increased the price target from $512 to $560, indicating a positive outlook for the stock.
The increase in price target from $512 to $560 by Citigroup suggests a positive outlook for Intuitive Surgical, likely leading to a short-term increase in stock price. The Buy rating reaffirms confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100